Affymetrix reports first-quarter total revenue of $80.2M Affymetrix, Inc., today reported its operating results for the first quarter of 2010. Total revenue for the one fourth was $80.2 million, as compared to total revenue of $78.6 million in the first quarter of 2009.4 million, services revenue was $4.5 million, and royalties and other revenue were $2.3 million. This compares to first quarter 2009 product revenue of $64.9 million, service revenue of $11.6 million, and royalties and other revenue of $2.1 million. Affymetrix shipped 40 systems in the first quarter of 2010. The Company reported a net loss of approximately $9.6 million, or $0.14 per diluted share, in the first one fourth of 2010 including an impairment charge of $4.9 million, or $0.07 per diluted share, on a nonmarketable expenditure.Kuo, M.D., M.B.A., Adeona’s Chairman and CEO. Before February 2 The offering is expected to close on or, 2011, at the mercy of customary closing circumstances, including approval by the NYSE AMEX. The net proceeds of approximately $3.7 million will be used for general corporate reasons, including conducting operations and advancing our medical development programs. Chardan Capital Marketplaces acted as the sole placement agent because of this transaction. The shares and warrants are being offered in a registered immediate offering beneath the Company’s effective shelf registration statement previously filed on Form S-3 with the Securities and Exchange Commission .